Cancer Res Treat.  2013 Sep;45(3):155-161.

Stereotactic Body Radiotherapy for Early Stage Lung Cancer

Affiliations
  • 1Department of Radiation Oncology, Hiroshima University, Hiroshima, Japan. nagat@hiroshima-u.ac.jp

Abstract

Stereotactic body radiation therapy (SBRT) is a newly developed technique currently in clinical use. SBRT originated from stereotactic radiosurgery for intracranial tumors. SBRT has been widely used clinically for lung cancer. The practice of SBRT demands different kinds of patient fixation, breathing control, target determination, treatment planning, and verifications. The history and current standard technique are reviewed. Clinical studies of lung cancer showed high local control rates with acceptable toxicities. Past and on-going clinical trials are reviewed.

Keyword

Radiosurgery; Early stage lung cancer; Stereotactic body radiation therapy; Stereotactic ablative radiotherapy; Stereotactic radiotherapy; Lung neoplasms; Conformal radiotherapy

MeSH Terms

Humans
Lung
Lung Neoplasms
Radiosurgery
Radiotherapy, Conformal
Respiration

Reference

1. Blomgren H, Lax I, Goranson H, Krapelien T, Nilsson B, Naslund I, et al. Radiosurgery for tumors in the body: clinical experience using a new method. J Radiosurg. 1998; 1:63–74.
Article
2. Uematsu M, Shioda A, Tahara K, Fukui T, Yamamoto F, Tsumatori G, et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer. 1998; 82:1062–1070. PMID: 9506350.
3. Onishi H, Kuriyama K, Komiyama T, Tanaka S, Sano N, Aikawa Y, et al. A new irradiation system for lung cancer combining linear accelerator, computed tomography, patient self-breath-holding, and patient-directed beam-control without respiratory monitoring devices. Int J Radiat Oncol Biol Phys. 2003; 56:14–20. PMID: 12694819.
Article
4. Negoro Y, Nagata Y, Aoki T, Mizowaki T, Araki N, Takayama K, et al. The effectiveness of an immobilization device in conformal radiotherapy for lung tumor: reduction of respiratory tumor movement and evaluation of the daily setup accuracy. Int J Radiat Oncol Biol Phys. 2001; 50:889–898. PMID: 11429216.
Article
5. Uematsu M, Shioda A, Suda A, Fukui T, Ozeki Y, Hama Y, et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys. 2001; 51:666–670. PMID: 11597807.
Article
6. Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Sakamoto T, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2005; 63:1427–1431. PMID: 16169670.
Article
7. Onimaru R, Shirato H, Shimizu S, Kitamura K, Xu B, Fukumoto S, et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys. 2003; 56:126–135. PMID: 12694831.
Article
8. Arimoto T, Usubuchi H, Matsuzawa T. Small volume multiple non-coplanar arc radiotherapy for tumors of the lund, head and neck and the abdominopelvic region. In : Lemke HU, editor. CAR'98 Computer assisted radiology and surgery. Tokyo: Elsevier;1998. p. 257–261.
9. Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010; 303:1070–1076. PMID: 20233825.
Article
10. Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys. 2004; 60:186–196. PMID: 15337555.
Article
11. Xia T, Li H, Sun Q, Wang Y, Fan N, Yu Y, et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2006; 66:117–125. PMID: 16765528.
Article
12. Baumann P, Nyman J, Hoyer M, Wennberg B, Gagliardi G, Lax I, et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol. 2009; 27:3290–3296. PMID: 19414667.
Article
13. Fowler JF. Sensitivity analysis of parameters in linear-quadratic radiobiologic modeling. Int J Radiat Oncol Biol Phys. 2009; 73:1532–1537. PMID: 19306749.
Article
14. Onishi H, Araki T, Shirato H, Nagata Y, Hiraoka M, Gomi K, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer. 2004; 101:1623–1631. PMID: 15378503.
15. Takeda A, Enomoto T, Sanuki N, Nakajima T, Takeda T, Sayama K, et al. Acute exacerbation of subclinical idiopathic pulmonary fibrosis triggered by hypofractionated stereotactic body radiotherapy in a patient with primary lung cancer and slightly focal honeycombing. Radiat Med. 2008; 26:504–507. PMID: 18975053.
Article
16. Nagata Y, Hiraoka M, Mizowaki T, Narita Y, Matsuo Y, Norihisa Y, et al. Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiother-apy Group. Int J Radiat Oncol Biol Phys. 2009; 75:343–347. PMID: 19735861.
Article
17. Corradetti MN, Haas AR, Rengan R. Central-airway necrosis after stereotactic body-radiation therapy. N Engl J Med. 2012; 366:2327–2329. PMID: 22694017.
Article
18. Timmerman R, McGarry R, Yiannoutsos C, Papiez L, Tudor K, DeLuca J, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006; 24:4833–4839. PMID: 17050868.
Article
19. Inoue T, Shimizu S, Onimaru R, Takeda A, Onishi H, Nagata Y, et al. Clinical outcomes of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer on radiologic examination. Int J Radiat Oncol Biol Phys. 2009; 75:683–687. PMID: 19231107.
Article
20. Chang JY, Balter PA, Dong L, Yang Q, Liao Z, Jeter M, et al. Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008; 72:967–971. PMID: 18954709.
Article
21. Miyamoto T, Baba M, Yamamoto N, Koto M, Sugawara T, Yashiro T, et al. Curative treatment of Stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen. Int J Radiat Oncol Biol Phys. 2007; 67:750–758. PMID: 17293232.
Article
22. Nagata Y, Wulf J, Lax I, Timmerman R, Zimmermann F, Stojkovski I, et al. Stereotactic radiotherapy of primary lung cancer and other targets: results of consultant meeting of the International Atomic Energy Agency. Int J Radiat Oncol Biol Phys. 2011; 79:660–669. PMID: 21281896.
Article
Full Text Links
  • CRT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr